XT
IMGN

XTX Topco’s Immunogen Inc IMGN Stock Holding History

XTX Topco’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,994
Closed -$80.6K – 1962
2023
Q1 		$80.6K Sell
20,994
-4,133
-16% -$17.6K 0.02% 1122
2022
Q4 		$125K Buy
+25,127
New +$136K 0.03% 960
2022
Q2 		– Sell
-12,941
Closed -$62K – 1163
2022
Q1 		$62K Buy
+12,941
New +$71.6K 0.03% 573

Other funds holding IMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

XTX Topco's IMGN Position: Q2 2023 in Review

XTX Topco sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 20,994 shares — an estimated $80.6K sold.

XTX Topco first reported a position in IMGN in Q1 2022 and held it in 3 quarters. The position peaked at $125K in Q4 2022. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • XTX Topco reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • XTX Topco sold 20,994 Immunogen Inc shares in Q2 2023, an estimated $80.6K.
  • XTX Topco first reported a position in Immunogen Inc in Q1 2022 and held it in 3 quarters.
  • XTX Topco's Immunogen Inc position peaked at $125K in Q4 2022.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.